1-5 of 5
erythropoietin receptor agonists
Close
Sort by
Journal Articles

Patient Blood Management: Implementation of a Preoperative Anemia Clinic for Elective Orthopedic Surgical Patients

Paul Letendre, MD, Emily Coberly, MD, Katie Dettenwanger, Kan Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2547.
https://doi.org/10.1182/blood-2018-99-113591
Published: 2018
Journal Articles

Activity of CNTO 530 in a Murine Model of Sickle Cell Anemia.

Dorie Makropoulos, BS, MT, Ram Achuthanandam, PhD, Patricia Rafferty, BA, HT, (ASCP), Denise Chroscinski, Kerry Brosnan, Lawrence Ogunkua, Andrew Miller, Justin Avery, Mindi Walker, PhD, Peter Bugelski, PhD
Journal: Blood
Blood (2009) 114 (22): 4606.
https://doi.org/10.1182/blood.V114.22.4606.4606
Published: 2009
Journal Articles

Red Blood Cell Transfusion and Chemotherapy Administration: A Study of Resource Utilization at the London Regional Cancer Program (LRCP).

Leonard Minuk, MD, Anargyros Xenocostas, MD, Anita Hibbert, Daphne Chan, PhD, Ian Chin-Yee, MD
Journal: Blood
Blood (2006) 108 (11): 4143.
https://doi.org/10.1182/blood.V108.11.4143.4143
Published: 2006
Journal Articles

Pharmacokinetics and Pharmacodynamics of CNTO 528, a Novel Erythropoietin Receptor Agonist in Normal and Anemic Rats.

Peter Bugelski, PhD, T. Nesspor, T. Spinka-Doms, D. Makropoulos, E. Eirikis, J. Fisher, A. Volk, K. Shamberger, I. James, P. Fisher, C. Pool, H. Jang, B. Miller, C. Huang, G. Heavner, D. Knight, J. Ghrayeb, B. Scallon
Journal: Blood
Blood (2005) 106 (11): 4261.
https://doi.org/10.1182/blood.V106.11.4261.4261
Published: 2005
Journal Articles

Preclinical Evaluation of Hematide™, a Novel Erythropoietic Receptor Agonist for the Treatment of Anemia Caused by Kidney Disease.

Kathryn W. Woodburn, PhD, Qing Fan, MD, Kerstin K. Leuther, PhD, Christopher P. Holmes, PhD, Jim J. Zhang, PhD, Svetlana Velkovska, MS, Min-jia Chen, MD, MS, Peter J. Schatz, PhD
Journal: Blood
Blood (2004) 104 (11): 2904.
https://doi.org/10.1182/blood.V104.11.2904.2904
Published: 2004